 |
PDBsum entry 1gg3
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Membrane protein
|
PDB id
|
|
|
|
1gg3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Biol
7:871-875
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Protein 4.1R core domain structure and insights into regulation of cytoskeletal organization.
|
|
B.G.Han,
W.Nunomura,
Y.Takakuwa,
N.Mohandas,
B.K.Jap.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of the core domain (N-terminal 30 kDa domain) of
cytoskeletal protein 4.1R has been determined and shows a cloverleaf-like
architecture. Each lobe of the cloverleaf contains a specific binding site for
either band 3, glycophorin C/D or p55. At a central region of the molecule near
where the three lobes are joined are two separate calmodulin (CaM) binding
regions. One of these is composed primarily of an alpha-helix and is Ca 2+
insensitive; the other takes the form of an extended structure and its binding
with CaM is dramatically enhanced by the presence of Ca 2+, resulting in the
weakening of protein 4.1R binding to its target proteins. This novel
architecture, in which the three lobes bind with three membrane associated
proteins, and the location of calmodulin binding sites provide insight into how
the protein 4.1R core domain interacts with membrane proteins and dynamically
regulates cell shape in response to changes in intracellular Ca2+ levels.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Space filling representation and stereo view of the
protein 4.1R core domain showing the binding regions for band 3,
glycophorin C/D, p55 and CaM. The color code for the binding
regions of band 3, glycophorin C/D, p55 and CaM is the same as
that used in Fig. 1d. a, Space filling representation of the
surface of the protein 4.1R core domain. Negatively charged
residues from the GPC binding region and positively charged
residues from the p55 binding region are colored in a darker
hue. Key amino acid residues that have been shown to be critical
for CaM binding are labeled: Ser 185 in the Ca^2+ sensitive CaM
binding region; and Trp 268, Phe 277, and Phe 278 in the Ca^2+
insensitive CaM binding region. Tyr 41 from the band 3 binding
sequence and Glu 246 from the p55 binding region are also
labeled. b, Space filling representation viewed from the
opposite side of the molecule shown in (a). Asp 216 and Glu 246
from the p55 binding region are labeled. c, Stereo view in the
same orientation as that in (a). Binding regions for band 3,
glycophorin C/D, and p55 are displayed in a translucent space
filling representation while CaM binding regions are presented
as ball-and-stick models. The Ca^ 2+ sensitive CaM binding
sequence (red) is organized in an extended structure while the
Ca^2+ insensitive CaM binding sequence (yellow) shows -helical
structure.
|
 |
Figure 3.
Figure 3. Space filling representations of CaM binding regions.
Amino acid residues on the surface are labeled. Hydrophobic
residues of the CaM binding sequence are colored white, polar
residues yellow, negatively charged residues red, and positively
charged residues blue. Key amino acid residues for CaM binding
are labeled red. Hydrophobic residues from distant regions of
the primary sequence that have folded to participate in the
formation of the hydrophobic patch of the CaM binding region are
shown in translucent white. a, Ca^2+ insensitive CaM binding
region showing a hydrophobic patch flanked by predominantly
positively charged residues. This patch has a high degree of
complementarity to the target peptide binding surface of the CaM
globular domain, which has a hydrophobic patch flanked by
negatively charged residues. Such complementarity is believed to
be a critical factor in CaM−target peptide interactions.
Hydrophobic residues (Trp 268, Phe 277 and Phe 278) of protein
4.1R are known to be critical for CaM binding; replacement of
these residues with Ala greatly affects CaM binding. The point
mutation W268S results in CaM binding becoming Ca^2+ sensitive.
b, Ca^2+ sensitive CaM binding region showing a hydrophobic
patch and the distribution of charged residues. This region is
formed by an extended structure. The polar residue Ser 185 is
found to be important for Ca^2+ dependent interactions with CaM;
the mutation S185W increases the binding affinity between this
site and CaM and abolishes the Ca^2+ dependence.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Struct Biol
(2000,
7,
871-875)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
N.M.Burton,
and
L.J.Bruce
(2011).
Modelling the structure of the red cell membrane.
|
| |
Biochem Cell Biol,
89,
200-215.
|
 |
|
|
|
|
 |
A.J.Baines
(2010).
The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life.
|
| |
Protoplasma,
244,
99.
|
 |
|
|
|
|
 |
C.Korsgren,
and
S.E.Lux
(2010).
The carboxyterminal EF domain of erythroid alpha-spectrin is necessary for optimal spectrin-actin binding.
|
| |
Blood,
116,
2600-2607.
|
 |
|
|
|
|
 |
P.R.Elliott,
B.T.Goult,
P.M.Kopp,
N.Bate,
J.G.Grossmann,
G.C.Roberts,
D.R.Critchley,
and
I.L.Barsukov
(2010).
The Structure of the talin head reveals a novel extended conformation of the FERM domain.
|
| |
Structure,
18,
1289-1299.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.Nunomura,
K.Kinoshita,
M.Parra,
P.Gascard,
X.An,
N.Mohandas,
and
Y.Takakuwa
(2010).
Similarities and differences in the structure and function of 4.1G and 4.1R135, two protein 4.1 paralogues expressed in erythroid cells.
|
| |
Biochem J,
432,
407-416.
|
 |
|
|
|
|
 |
H.Kusunoki,
and
T.Kohno
(2009).
Solution structure and glycophorin C binding studies of the protein 4.1R FERM alpha-lobe domain.
|
| |
Proteins,
76,
255-260.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.S.Seo,
J.J.Jeong,
L.Zeng,
C.G.Takoudis,
B.J.Quinn,
A.A.Khan,
T.Hanada,
and
A.H.Chishti
(2009).
Alternatively spliced exon 5 of the FERM domain of protein 4.1R encodes a novel binding site for erythrocyte p55 and is critical for membrane targeting in epithelial cells.
|
| |
Biochim Biophys Acta,
1793,
281-289.
|
 |
|
|
|
|
 |
Q.Kang,
Y.Yu,
X.Pei,
R.Hughes,
S.Heck,
X.Zhang,
X.Guo,
G.Halverson,
N.Mohandas,
and
X.An
(2009).
Cytoskeletal protein 4.1R negatively regulates T-cell activation by inhibiting the phosphorylation of LAT.
|
| |
Blood,
113,
6128-6137.
|
 |
|
|
|
|
 |
S.Ficarra,
E.Tellone,
B.Giardina,
R.Scatena,
A.Russo,
F.Misiti,
M.E.Clementi,
D.Colucci,
E.Bellocco,
G.Laganà,
D.Barreca,
and
A.Galtieri
(2009).
Derangement of erythrocytic AE1 in beta-thalassemia by caspase 3: pathogenic mechanisms and implications in red blood cell senescence.
|
| |
J Membr Biol,
228,
43-49.
|
 |
|
|
|
|
 |
D.B.Bernkopf,
and
E.D.Williams
(2008).
Potential role of EPB41L3 (protein 4.1B/Dal-1) as a target for treatment of advanced prostate cancer.
|
| |
Expert Opin Ther Targets,
12,
845-853.
|
 |
|
|
|
|
 |
M.Salomao,
X.Zhang,
Y.Yang,
S.Lee,
J.H.Hartwig,
J.A.Chasis,
N.Mohandas,
and
X.An
(2008).
Protein 4.1R-dependent multiprotein complex: new insights into the structural organization of the red blood cell membrane.
|
| |
Proc Natl Acad Sci U S A,
105,
8026-8031.
|
 |
|
|
|
|
 |
K.L.Wegener,
A.W.Partridge,
J.Han,
A.R.Pickford,
R.C.Liddington,
M.H.Ginsberg,
and
I.D.Campbell
(2007).
Structural basis of integrin activation by talin.
|
| |
Cell,
128,
171-182.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.E.Clementi,
B.Giardina,
D.Colucci,
A.Galtieri,
and
F.Misiti
(2007).
Amyloid-beta peptide affects the oxygen dependence of erythrocyte metabolism: a role for caspase 3.
|
| |
Int J Biochem Cell Biol,
39,
727-735.
|
 |
|
|
|
|
 |
A.J.Baines
(2006).
A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function.
|
| |
BMC Genomics,
7,
85.
|
 |
|
|
|
|
 |
D.F.Ceccarelli,
H.K.Song,
F.Poy,
M.D.Schaller,
and
M.J.Eck
(2006).
Crystal structure of the FERM domain of focal adhesion kinase.
|
| |
J Biol Chem,
281,
252-259.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Tarpey,
S.Thomas,
N.Sarvananthan,
U.Mallya,
S.Lisgo,
C.J.Talbot,
E.O.Roberts,
M.Awan,
M.Surendran,
R.J.McLean,
R.D.Reinecke,
A.Langmann,
S.Lindner,
M.Koch,
S.Jain,
G.Woodruff,
R.P.Gale,
C.Degg,
K.Droutsas,
I.Asproudis,
A.A.Zubcov,
C.Pieh,
C.D.Veal,
R.D.Machado,
O.C.Backhouse,
L.Baumber,
C.S.Constantinescu,
M.C.Brodsky,
D.G.Hunter,
R.W.Hertle,
R.J.Read,
S.Edkins,
S.O'Meara,
A.Parker,
C.Stevens,
J.Teague,
R.Wooster,
P.A.Futreal,
R.C.Trembath,
M.R.Stratton,
F.L.Raymond,
and
I.Gottlob
(2006).
Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus.
|
| |
Nat Genet,
38,
1242-1244.
|
 |
|
|
|
|
 |
N.Terada,
N.Ohno,
H.Yamakawa,
O.Ohara,
and
S.Ohno
(2005).
Topographical significance of membrane skeletal component protein 4.1 B in mammalian organs.
|
| |
Anat Sci Int,
80,
61-70.
|
 |
|
|
|
|
 |
I.Behrmann,
T.Smyczek,
P.C.Heinrich,
H.Schmitz-Van de Leur,
W.Komyod,
B.Giese,
G.Müller-Newen,
S.Haan,
and
C.Haan
(2004).
Janus kinase (Jak) subcellular localization revisited: the exclusive membrane localization of endogenous Janus kinase 1 by cytokine receptor interaction uncovers the Jak.receptor complex to be equivalent to a receptor tyrosine kinase.
|
| |
J Biol Chem,
279,
35486-35493.
|
 |
|
|
|
|
 |
B.Giese,
C.K.Au-Yeung,
A.Herrmann,
S.Diefenbach,
C.Haan,
A.Küster,
S.B.Wortmann,
C.Roderburg,
P.C.Heinrich,
I.Behrmann,
and
G.Müller-Newen
(2003).
Long term association of the cytokine receptor gp130 and the Janus kinase Jak1 revealed by FRAP analysis.
|
| |
J Biol Chem,
278,
39205-39213.
|
 |
|
|
|
|
 |
C.M.Luque,
C.M.Pérez-Ferreiro,
A.Pérez-Gonzalez,
L.Englmeier,
M.D.Koffa,
and
I.Correas
(2003).
An alternative domain containing a leucine-rich sequence regulates nuclear cytoplasmic localization of protein 4.1R.
|
| |
J Biol Chem,
278,
2686-2691.
|
 |
|
|
|
|
 |
D.S.Libich,
C.M.Hill,
I.R.Bates,
F.R.Hallett,
S.Armstrong,
A.Siemiarczuk,
and
G.Harauz
(2003).
Interaction of the 18.5-kD isoform of myelin basic protein with Ca2+ -calmodulin: effects of deimination assessed by intrinsic Trp fluorescence spectroscopy, dynamic light scattering, and circular dichroism.
|
| |
Protein Sci,
12,
1507-1521.
|
 |
|
|
|
|
 |
S.Chauhan,
R.Pandey,
J.F.Way,
T.C.Sroka,
M.C.Demetriou,
S.Kunz,
A.E.Cress,
D.W.Mount,
and
R.L.Miesfeld
(2003).
Androgen regulation of the human FERM domain encoding gene EHM2 in a cell model of steroid-induced differentiation.
|
| |
Biochem Biophys Res Commun,
310,
421-432.
|
 |
|
|
|
|
 |
T.Hanada,
A.Takeuchi,
G.Sondarva,
and
A.H.Chishti
(2003).
Protein 4.1-mediated membrane targeting of human discs large in epithelial cells.
|
| |
J Biol Chem,
278,
34445-34450.
|
 |
|
|
|
|
 |
W.J.Smith,
N.Nassar,
A.Bretscher,
R.A.Cerione,
and
P.A.Karplus
(2003).
Structure of the active N-terminal domain of Ezrin. Conformational and mobility changes identify keystone interactions.
|
| |
J Biol Chem,
278,
4949-4956.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.A.Calderwood,
B.Yan,
J.M.de Pereda,
B.G.Alvarez,
Y.Fujioka,
R.C.Liddington,
and
M.H.Ginsberg
(2002).
The phosphotyrosine binding-like domain of talin activates integrins.
|
| |
J Biol Chem,
277,
21749-21758.
|
 |
|
|
|
|
 |
D.S.Libich,
and
G.Harauz
(2002).
Interactions of the 18.5-kDa isoform of myelin basic protein with Ca(2+)-calmodulin: in vitro studies using fluorescence microscopy and spectroscopy.
|
| |
Biochem Cell Biol,
80,
395-406.
|
 |
|
|
|
|
 |
M.J.Tanner
(2002).
Band 3 anion exchanger and its involvement in erythrocyte and kidney disorders.
|
| |
Curr Opin Hematol,
9,
133-139.
|
 |
|
|
|
|
 |
M.Nakao
(2002).
New insights into regulation of erythrocyte shape.
|
| |
Curr Opin Hematol,
9,
127-132.
|
 |
|
|
|
|
 |
S.W.Krauss,
R.Heald,
G.Lee,
W.Nunomura,
J.A.Gimm,
N.Mohandas,
and
J.A.Chasis
(2002).
Two distinct domains of protein 4.1 critical for assembly of functional nuclei in vitro.
|
| |
J Biol Chem,
277,
44339-44346.
|
 |
|
|
|
|
 |
T.Shimizu,
A.Seto,
N.Maita,
K.Hamada,
S.Tsukita,
S.Tsukita,
and
T.Hakoshima
(2002).
Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.
|
| |
J Biol Chem,
277,
10332-10336.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Scott,
G.W.Phillips,
and
A.J.Baines
(2001).
Properties of the C-terminal domain of 4.1 proteins.
|
| |
Eur J Biochem,
268,
3709-3717.
|
 |
|
|
|
|
 |
L.J.Huang,
S.N.Constantinescu,
and
H.F.Lodish
(2001).
The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor.
|
| |
Mol Cell,
8,
1327-1338.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |